Literature DB >> 32799490

Iron Complexes of an Antiproliferative Aroyl Hydrazone: Characterization of Three Protonation States by Electron Paramagnetic Resonance Methods.

Andrei V Astashkin1, Rachel D Utterback1, Yu-Shien Sung1, Elisa Tomat1.   

Abstract

Tridentate aroyl hydrazones are efn class="Chemical">fective metal chelators in biological settings, and their activity has been investigated extensively for medicinal applications in metal overload, cancer, and neurodegenerative diseases. The aroyl hydrazone motif is found in the recently reported prochelator (AH1-S)2, which has shown antiproliferative proapoptotic activity in mammalian cancer cell lines. Intracellular reduction of this disulfide prochelator leads to the formation of mercaptobenzaldehyde benzoylhydrazone chelator AH1 and to iron sequestration, which in turn impacts cell growth. Herein, we investigate the iron coordination chemistry of AH1 to determine the structural and spectroscopic properties of the iron complexes in the solid state and in solution. A neutral iron(III) complex of 2:1 ligand-to-metal stoichiometry was isolated and characterized fully to reveal two different binding modes for the tridentate AH1 ligand. Specifically, one ligand binds in the monoanionic keto form, whereas the other ligand coordinates as a dianionic enolate. Continuous-wave electron paramagnetic resonance experiments in frozen solutions indicated that this neutral complex is one of three low-spin iron(III) complexes observed depending on the pH of the solution. Electron spin echo envelope modulation (ESEEM) experiments allowed assignment of the three species to different protonation states of the coordinated ligands. Our ESEEM analysis provides a method to distinguish the coordination of aroyl hydrazones in the keto and enolate forms, which influences both the ligand field and overall charge of the complex. As such, this type of analysis could provide valuable information in a variety of studies of iron complexes of aroyl hydrazones, ranging from the investigation of spin-crossover behavior to tracking of their distribution in biological samples.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32799490      PMCID: PMC8223696          DOI: 10.1021/acs.inorgchem.0c01120

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  34 in total

Review 1.  Iron and Cancer.

Authors:  Suzy V Torti; David H Manz; Bibbin T Paul; Nicole Blanchette-Farra; Frank M Torti
Journal:  Annu Rev Nutr       Date:  2018-08-21       Impact factor: 11.848

2.  A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents.

Authors:  P Ponka; J Borová; J Neuwirt; O Fuchs; E Necas
Journal:  Biochim Biophys Acta       Date:  1979-08-22

3.  Crystal and molecular structure of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone (NIH) and its iron(III) complex: an iron chelator with anti-tumour activity.

Authors:  D R Richardson; P V Bernhardt
Journal:  J Biol Inorg Chem       Date:  1999-06       Impact factor: 3.358

4.  The antioxidant effects of a novel iron chelator salicylaldehyde isonicotinoyl hydrazone in the prevention of H(2)O(2) injury in adult cardiomyocytes.

Authors:  M Horackova; P Ponka; Z Byczko
Journal:  Cardiovasc Res       Date:  2000-08-18       Impact factor: 10.787

5.  2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.

Authors:  Des R Richardson; Danuta S Kalinowski; Vera Richardson; Philip C Sharpe; David B Lovejoy; Mohammad Islam; Paul V Bernhardt
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

6.  Tuning the antiproliferative activity of biologically active iron chelators: characterization of the coordination chemistry and biological efficacy of 2-acetylpyridine and 2-benzoylpyridine hydrazone ligands.

Authors:  Paul V Bernhardt; Gregory J Wilson; Philip C Sharpe; Danuta S Kalinowski; Des R Richardson
Journal:  J Biol Inorg Chem       Date:  2007-09-25       Impact factor: 3.358

7.  Intracellular reduction/activation of a disulfide switch in thiosemicarbazone iron chelators.

Authors:  Eman A Akam; Tsuhen M Chang; Andrei V Astashkin; Elisa Tomat
Journal:  Metallomics       Date:  2014-08-07       Impact factor: 4.526

8.  SHELXT - integrated space-group and crystal-structure determination.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A Found Adv       Date:  2015-01-01       Impact factor: 2.290

9.  Crystal structure refinement with SHELXL.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

Review 10.  Targeting iron metabolism in drug discovery and delivery.

Authors:  Bart J Crielaard; Twan Lammers; Stefano Rivella
Journal:  Nat Rev Drug Discov       Date:  2017-02-03       Impact factor: 84.694

View more
  2 in total

1.  Aroylhydrazone Glycoconjugate Prochelators Exploit Glucose Transporter 1 (GLUT1) to Target Iron in Cancer Cells.

Authors:  Yu-Shien Sung; Baris Kerimoglu; Aikseng Ooi; Elisa Tomat
Journal:  ACS Med Chem Lett       Date:  2022-08-18       Impact factor: 4.632

2.  Albumin Conjugates of Thiosemicarbazone and Imidazole-2-thione Prochelators: Iron Coordination and Antiproliferative Activity.

Authors:  Yu-Shien Sung; Wangbin Wu; Megan A Ewbank; Rachel D Utterback; Michael T Marty; Elisa Tomat
Journal:  ChemMedChem       Date:  2021-06-10       Impact factor: 3.540

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.